Carrilho F J, Mendes Clemente C, Silva L C da
Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.
Gastroenterol Hepatol. 2005 Mar;28(3):118-25. doi: 10.1157/13072011.
This review has the objective to discuss the epidemiological aspects of the enterically transmitted hepatitis A and E in Brazil. The prevalence of hepatitis A varies greatly in different Brazilian regions, from 56% in South and Southeast to 93% in North region (Manaus, Amazon). Such differences are also found in different socioeconomic levels among age groups. A significantly higher prevalence was seen in the low socioeconomic group between 1-30 years. This difference is most striking in the first 10 years of age (23.5% vs 60.0%, high/middle vs low, respectively). Despite the improvements in sanitary conditions, hepatitis A is still endemic and outbreaks may occur. As an increasing proportion of the population is becoming susceptible to hepatitis A virus infection and as adult individuals may present more severe forms of the disease, the authors conclude that the implement of hepatitis A vaccination should be considered. Some Brazilian data have shown that the genotype found in our country were IA and IB. Isolates from this study were closely related genetically (or even identical) to isolates originating in other South American countries and overseas, providing firm evidence for epidemiological links between persons who travel to endemic areas. In spite of favorable environmental conditions, outbreaks of hepatitis E have never been reported in Brazil. Nevertheless, reports have demonstrated the evidence of anti-hepatitis E virus antibodies in some Brazilian regions. The seroprevalence of IgG anti-hepatitis E virus among normal populations shows positivities of 6.1% in gold-miners, 3.3% in general population, 2.0-7.5% in blood donors, 1.0% in pregnant women, and 4.5% in children, with no differences among regions. In populations at risk the prevalence of anti-hepatits E virus varies greatly. Among patients with acute non-A, non-B, non-C hepatitis 2.1% was detected in the Southeast to 29% in the Northeast, in 10.6% of acute non-A, non-B, non-C hepatitis relatives in the Amazon basin, in 12% of acute sporadic non-A non-B hepatitis patients in the Northeast, a co-infection with acute hepatitis A in 25 to 38% in the Northeast, in 14 to 18% among prostitutes and women considered at risk for human immunodeficiency virus in the Southeast, and in 12% of the intravenous drug users in the Southeast.
本综述旨在探讨巴西经肠道传播的甲型和戊型肝炎的流行病学情况。巴西不同地区甲型肝炎的患病率差异很大,从南部和东南部的56%到北部地区(玛瑙斯,亚马逊地区)的93%。不同年龄组的不同社会经济水平也存在这种差异。1至30岁的低社会经济群体中患病率显著更高。这种差异在10岁前最为明显(分别为23.5%对60.0%,高/中对低)。尽管卫生条件有所改善,但甲型肝炎仍然是地方性疾病,可能会发生疫情。由于越来越多的人口易感染甲型肝炎病毒,且成年人可能表现出更严重的疾病形式,作者得出结论,应考虑实施甲型肝炎疫苗接种。一些巴西数据表明,在我国发现的基因型为IA和IB。本研究的分离株在基因上与源自其他南美国家和海外的分离株密切相关(甚至相同),为前往流行地区的人员之间的流行病学联系提供了确凿证据。尽管环境条件有利,但巴西从未报告过戊型肝炎疫情。然而,报告显示在巴西一些地区存在抗戊型肝炎病毒抗体的证据。正常人群中抗戊型肝炎病毒IgG的血清阳性率在金矿工人中为6.1%,在普通人群中为3.3%,在献血者中为2.0 - 7.5%,在孕妇中为1.0%,在儿童中为4.5%,各地区之间无差异。在高危人群中,抗戊型肝炎病毒的患病率差异很大。在急性非甲、非乙、非丙型肝炎患者中,东南部检测到2.1%,东北部为29%;在亚马逊盆地急性非甲、非乙、非丙型肝炎患者的亲属中为10.6%;在东北部急性散发性非甲非乙型肝炎患者中为12%;在东北部,与急性甲型肝炎合并感染的比例为25%至38%;在东南部,妓女和被认为有感染人类免疫缺陷病毒风险的女性中为14%至18%;在东南部静脉吸毒者中为12%。